Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 82 Show results per page	View Search Criteria \| Help With Results


1.		A Randomized Study of Liposomal Doxorubicin in Women With Breast Cancer Exploiting Tissue Doppler Imaging

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Diagnostic, Treatment				Active				18 to 65				Other				LITE Randomized Pilot Study NCT00531973


2.		Yunzhi as Dietary Supplement in Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Active				18 and over				Other				YUNZHI-BC NCT00647075

Last Modified: 12/17/2008 First Published: 3/16/2007


3.		Phase II/III Randomized Study of Neoadjuvant and Adjuvant Chemotherapy Comprising Epirubicin Hydrochloride, Cisplatin, and Capecitabine With or Without Bevacizumab in Patients With Previously Untreated, Resectable Gastric or Gastroesophageal Junction Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Active				18 and over				Other				MRC-ST03 EU-20710, ISRCTN46020948, EUDRACT-2006-000811-12, CTA-00316/0221/001, NCT00450203

Last Modified: 9/10/2008 First Published: 8/1/2001


4.		Phase III Randomized Study of Adjuvant Induction Chemotherapy With or Without Cyclophosphamide and Methotrexate as Maintenance Chemotherapy in Patients With Stage I, II, or III Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Not specified				Other				IBCSG-22-00 EU-20119, NCT00022516, EUDRACT-2005-005666-36

Last Modified: 5/18/2007 First Published: 7/1/2002


5.		Phase III Randomized Study of Neoadjuvant Cisplatin and Fluorouracil Versus Cisplatin, Epirubicin, and Fluorouracil in Patients With Resectable Adenocarcinoma of the Esophagus

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Not specified				Other				MRC-OE05 EU-20204, NCT00041262

Last Modified: 8/9/2007 First Published: 10/1/2002


6.		Phase III Randomized Study of Fluorouracil, Epirubicin, and Cyclophosphamide Versus Docetaxel, Epirubicin, and Cyclophosphamide in Women With Primary Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 to 70				Other				LMU-ADEBAR EU-20221, NCT00047099

Last Modified: 1/14/2009 First Published: 11/24/2002


7.		Phase III Randomized Study of Adjuvant Chemoradiation After Resection in Patients With Gastric or Gastroesophageal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				NCI				CALGB-80101 NCCTG-CALGB-80101, ECOG-CALGB-80101, NCT00052910


8.		Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Not specified				Other				ID99-146 NCT00038402


9.		A Multicenter Trial Comparing Induction C/T Followed by CCRT v.s. CCRT Alone in Stage IV Nasopharyngeal Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				Under 70				Other				T1303 NCT00201396


10.		Nexium Study To Suppress Nausea During Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Active				18 and over				Other				H-16348 Nexium Study, NCT00206440

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute